This report provides updated baseline data for monitoring future changes in the distribution of autochthonous Crimean-Congo haemorrhagic fever and its associated vectors for Europe and its neighbouring areas.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 3-9 December 2023 and includes updates on respiratory virus epidemiology in the EU/EEA, SARS-CoV-2 variant classification, measles, mpox, Mycoplasma pneumoniae, West Nile virus, and MERS-CoV.
Since the beginning of the 2023 transmission season and as of 6 December 2023, EU/EEA countries have reported 707 human cases of WNV infection in Italy (336), Greece (162, of which 1 with unknown place of infection).
Since the beginning of the 2023 transmission season and as of 6 December 2023, EU/EEA countries have reported 707 human cases of WNV infection, 152 outbreaks among equids and 247 outbreaks among birds.
Since the beginning of the 2023 transmission season and as of 6 December 2023, EU/EEA countries have reported 707 human cases of WNV infection in Italy (336), Greece (162, of which 1 with unknown place of infection).
Weekly updates with the latest reports on West Nile virus cases in Europe. Interactive maps and tables updated every Friday, during the transmission season.
Since the beginning of 2023, and as of 5 December 2023, two MERS-CoV cases have been reported with the date of onset in 2023 by the United Arab Emirates (1) and Saudi Arabia (1).
Since the beginning of 2023, and as of 5 December 2023, two MERS-CoV cases have been reported with the date of onset in 2023 by the United Arab Emirates (1) and Saudi Arabia (1).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 26 November - 2 December 2023 and includes updates on human infection with influenza A(H1N2)v, influenza A(H5N1), an overview of respiratory virus epidemiology in the EU/EEA, respiratory infections due to Mycoplasma pneumoniae in the EU/EEA, HIV/AIDS surveillance 2023 (2022 data), West Nile virus, SARS-CoV-2 variant classification, and poliomyelitis.